George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
LOL!!!!!!!!!!!! Barder investing in FUM shares? I bet if you look back at all his "purchases", they're through cheap share options or "bought" via a massive bonus like last year's placing. This guy has made millions over the years via a huge salary out of a company that has never made a profit!
As for all these so called experts talking dermasys up, they're the same so called experts who talked MED up.
The Market is saying SELL
Strong sell
If Ralph - who is a genuine & influential heavyweight in the ED field - believes what he asserts, then doubtless FUM would be happy for him to present the data at a national/international meeting (all expenses paid, natch), which would give them valuable publicity, but open it up to peer scrutiny.
The title could be "We trialed our product against a placebo, and as a consequence have decided to market the placebo!"
Standing room only, I would guess. Don't see it happening. Ditto the hoped-for paper in a scientific journal.
You've got to feel sorry for the Barder family (not to mention all PI's), who have invested real money into this product. Unlike the two time-expired ex-GSK board members, James & Clarke, with their comfortable pensions, these people are bleeding. Amazing that they are still taking advice from the main architects of this debacle. I guess they think that they have enough influence to swing it for them, with the FDA. But the FDA deal in facts.
For James & Clarke, bringing an erectogenic gel to market is hardly the pinnacle of their careers - these people are used to dealing with big Pharma at the top level. I doubt if James even bothered to evaluate the formulation for potential vasoactivity. Presumably he just assumed that DS' rapid clearance was simply a factor of its molecular configuration, without asking himself whether this was being assisted by increased blood-flow with a dilated sub-dermal venous plexus.
They really need good-quality independent advice.
Nailed it blaustein. How do we get a true independent when the medical world is has a dark pool of driven money. Plenty of examples of 'independents experts' supporting drugs not all of which are best for the public and some of which that have wrecked or cost lives. Even our GP's are pressured by incentives to prescribe drugs that aren't always what are in patients best interests.
Thirty pieces of silver is a common gift of pharmaceuticals.
Wonder if this was one of the 20 possible outcomes, of which only 1 was failure. What crap management. CEO is a clueless joker.
Martin - I may be wrong, but was not Ralph jointly involved with the trials? I hope I am not misleading you - relying on possibly faulty memory!
It happens frequently that drug companies elicit endorsements from clinicians responsible for their drug evaluation, and they are rarely not forthcoming!
I’m thinking of Professor Ralph ,who one would hope is being objective ,and seemed very impressed with the results.Surly he will have been shown the full data.
The best thing that the BOD could do to restore confidence is to bring in a really competent chemist with a decent rep, and get DS sorted! By all means keep Ken as a figurehead - his name may have some pull with the regulatory authorities.
The tragedy is that they may have a really hot product on their hands.
r
I would like to see Ken James clarify what substances have been used as a placebo in the P-K study, & phases 2 and 3, explaining the reasons for any changes.
If the placebo provided in phase 3 was dosed with GTN somehow, similar results would have occurred.
Hearing the company state that placebo was checked for presence of GTN as part of Quality Assurance would now be appropriate.
Martin - Why doesn't Ken put himself up for a live Sharechat with a few of his happy investors? That should be fun! He's OK waffling on about drug products & licensing procedures (done it for years), but put him up against an independent expert & he could easily get torn apart (& then where would the SP go?).
Remember - he doesn't even seem to know whether DS is a placebo or a drug!
Any LTH tried to ring IR today?
'What I think the board needs to do is to invite one of the independent ED experts to discuss the findings with Ken on camera.URGENTLY.'
The board thought that 'everyone will be excited'. Well clearly they are not and the above suggestion from martinelwick really is a sensible course of action for them to take.
I guess we could all make a pretty good stab at TB's identity. The tragedy is that the BOD also seem heavily influenced by him.
I have gone back and listened to the webcast from FUM, and studied the slides. Against the internationally recognised base line criteria IIEF....DermaSys recorded an efficacy score of 80% in ED sufferers with a SEVERE condition.Moreover adverse reactions are almost zero.
What I think the board needs to do is to invite one of the independent ED experts to discuss the findings with Ken on camera.URGENTLY.
ThomasBrown will be back under a different name but his baby chav writing style will be a big give away.....LOL
as he repeatedly said at the end of each fkn dreary repetitive sentence ….LOL
He wrote reams of absolute unfounded drivel...I used to wind him up...I was probs wrong for that ..duno…
But ya gota feel sorry for the peeps who bought in under his advice the sad little CK SKR
All said.... this will deffo re rate back to the 30s soon.....it always does....been in this for years....As Ive said a thousand time with this share...You can read this cycle like a Janet and John book....
NOWWWWW is the time to buy...…..This is bargain city
They should release something soon as that’s a £34k sell
Agree. We need to know if there is an active vasoactive molecule in the DS formulation. If so, it has to undergo proper trials. This is what the FDA will want to know. Or do this bunch of loons expect American males to anoint their nether regions with a preparation of unquantified efficacy? It's either a placebo or it isn't. Simples.
The BOD are just spinning their wheels, the SP is in effective free-fall, barring the usual spikes & dips, and Thomas Browne has gone AWOL. I think Ken should go out & find him - his audience awaits.
Whith matters of the nether regions, puns are difficult to avoid, intended or not !
Pun intended?
Until FUM can verify scientifically how and why DermaSys works for ED, they are in snake oil territory.
There is a significant probability that effects seen so far are purely psychological IMHO.
So, it is vital that they get to the bottom of this out asap.
Their RNS didn't cut the mustard for me.